|
Apr 24
|
bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth
|
|
Jan 30
|
bioAffinity Technologies In The News
|
|
Dec 5
|
bioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of Directors
|
|
Nov 30
|
CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024
|
|
Nov 28
|
bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post
|
|
Nov 6
|
bioAffinity Technologies Names Dallas J. Coleman as National Director of Sales
|
|
Apr 25
|
bioAffinity Technologies Presents at Cleveland Clinic Lung Cancer Symposium
|